Original Research

Published on 07 Nov 2023

MiR-124-3p mediates gastric cancer cell ferroptosis induced by an anti-cancer drug polyphyllin I

in Pharmacology of Anti-Cancer Drugs

Fang Zheng
Jian-Can Bi
Yu-Yan Wei
Yeshu Wang
Qunfang Zhang
Chun-Ling Liang
Jianwei Wu
Zhenhua Dai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1285799

1,749 views
1 citation

Editorial

Published on 07 Nov 2023

Editorial: The use of plant metabolites to ameliorate sequelae of chemotherapy

in Pharmacology of Anti-Cancer Drugs

Cijo George Vazhappilly
Shoib Sarwar Siddiqui
Ruby John Anto
Rajan Radhakrishnan
Naveen Kumar Devanga Ragupathi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1320139

732 views

Original Research

Published on 06 Nov 2023

Cathepsin V regulates cell cycle progression and histone stability in the nucleus of breast cancer cells

in Pharmacology of Anti-Cancer Drugs

Naphannop Sereesongsaeng
James F. Burrows
Christopher J. Scott
Klaudia Brix
Roberta E. Burden

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1271435

2,367 views
7 citations

Original Research

Published on 02 Nov 2023

Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR

in Pharmacology of Anti-Cancer Drugs

Yuval Bin Kanner
Qiu-Xu Teng
Assaf Ganoth
Dan Peer
Jing-Quan Wang
Zhe-Sheng Chen
Yossi Tsfadia

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1290255

2,990 views
4 citations

Original Research

Published on 02 Nov 2023

Survival nomogram for medulloblastoma and multi-center external validation cohort

in Pharmacology of Anti-Cancer Drugs

Xiang Li
Jian Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1247812

1,548 views
3 citations

Mini Review

Published on 02 Nov 2023

The anti-leukemia activity and mechanisms of shikonin: a mini review

in Pharmacology of Anti-Cancer Drugs

Han Dong
Chun-Di Chang
Fei Gao
Na Zhang
Xing-Jian Yan
Xue Wu
Yue-Hui Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1271252

1,513 views
3 citations

Editorial

Published on 02 Nov 2023

Editorial: Evolution of phytochemicals and phytotherapies in the treatment and management of cancer: targeted strategies in cancer precision medicine

in Pharmacology of Anti-Cancer Drugs

Mohd Adnan
Visweswara Rao Pasupuleti
Mitesh Patel

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1326474

1,131 views
1 citation

Editorial

Published on 31 Oct 2023

Editorial: Chromatographic analytical methods for quantifying newly marketed targeted antitumor drugs

in Pharmacology of Anti-Cancer Drugs

Shashank Kumar

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1308336

794 views

Case Report

Published on 31 Oct 2023

Case report: Clinical management of recurrent small cell lung cancer transformation complicated with lung cancer-induced acute pancreatitis after lung adenocarcinoma surgery

in Pharmacology of Anti-Cancer Drugs

Suyun Zhang
Ningjing Guo
Qianyuan Zhang
Yao Wang
Sheng Yang
Xiangqi Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1259221

1,372 views

Original Research

Published on 31 Oct 2023

Hematologic and lymphatic system toxicities associated with immune checkpoint inhibitors: a real-world study

in Pharmacology of Anti-Cancer Drugs

Na Li
Yong Feng
XiaoLing Chen
Ye Li
Chengmiao Zhang
Yin Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1213608

1,605 views
2 citations

Original Research

Published on 30 Oct 2023

Prediction of the mechanism for the combination of diallyl trisulfide and cisplatin against gastric cancer: a network pharmacology study and pharmacological evaluation

in Pharmacology of Anti-Cancer Drugs

Huaiyou Lv
Xiumei Jia
Huatian Yang
Xiaosong Zhu
Zhongxi Zhao
Xiaoyan Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1269895

1,776 views
1 citation

Original Research

Published on 30 Oct 2023

Cost-effectiveness analysis of first-line tislelizumab plus chemotherapy for recurrent or metastatic nasopharyngeal cancer

in Pharmacology of Anti-Cancer Drugs

Zhengda Pei
Ningping Xiao
Pei Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1265784

1,755 views

Review

Published on 26 Oct 2023

PARP inhibitors combined with radiotherapy: are we ready?

in Pharmacology of Anti-Cancer Drugs

Chen Sun
Alan Chu
Rui Song
Shijia Liu
Ting Chai
Xin Wang
Zongwen Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1234973

5,316 views
9 citations

Original Research

Published on 26 Oct 2023

Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia

in Pharmacology of Anti-Cancer Drugs

Tomislav Smoljo
Barbara Tomic
Hrvoje Lalic
Vilma Dembitz
Josip Batinic
Antonio Bedalov
Dora Visnjic

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1258151

2,310 views
1 citation

Original Research

Published on 26 Oct 2023

Identification of a prognostic evaluator from glutamine metabolic heterogeneity studies within and between tissues in hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Jie Bao
Yan Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1241677

1,479 views
1 citation

Review

Published on 25 Oct 2023

Anaplastic lymphoma kinase inhibitors—a review of anticancer properties, clinical efficacy, and resistance mechanisms

in Pharmacology of Anti-Cancer Drugs

Kajetan Kiełbowski
Justyna Żychowska
Rafał Becht

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1285374

3,179 views
4 citations

Navigation group

Articles

MiR-124-3p mediates gastric cancer cell ferroptosis induced by an anti-cancer drug polyphyllin I

Editorial: The use of plant metabolites to ameliorate sequelae of chemotherapy

Cathepsin V regulates cell cycle progression and histone stability in the nucleus of breast cancer cells

Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR

Survival nomogram for medulloblastoma and multi-center external validation cohort

The anti-leukemia activity and mechanisms of shikonin: a mini review

Editorial: Evolution of phytochemicals and phytotherapies in the treatment and management of cancer: targeted strategies in cancer precision medicine

Editorial: Chromatographic analytical methods for quantifying newly marketed targeted antitumor drugs

Case report: Clinical management of recurrent small cell lung cancer transformation complicated with lung cancer-induced acute pancreatitis after lung adenocarcinoma surgery

Hematologic and lymphatic system toxicities associated with immune checkpoint inhibitors: a real-world study

Prediction of the mechanism for the combination of diallyl trisulfide and cisplatin against gastric cancer: a network pharmacology study and pharmacological evaluation

Cost-effectiveness analysis of first-line tislelizumab plus chemotherapy for recurrent or metastatic nasopharyngeal cancer

PARP inhibitors combined with radiotherapy: are we ready?

Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia

Identification of a prognostic evaluator from glutamine metabolic heterogeneity studies within and between tissues in hepatocellular carcinoma

Anaplastic lymphoma kinase inhibitors—a review of anticancer properties, clinical efficacy, and resistance mechanisms